amoxicillin has been researched along with Tuberculosis, Drug-Resistant in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biava, M; Cocozza, M; Consalvi, S; Poce, G | 1 |
| De Wit, S; Payen, MC | 1 |
| Butler-Laporte, G; Menzies, D; Winters, N | 1 |
| Lu, J; Pang, Y; Wang, Y; Zhang, D | 1 |
| Ahuja, S; Benedetti, A; Cox, H; Fox, GJ; Koh, WJ; Menzies, D; Pasvol, G; Viiklepp, P | 1 |
| Drobniewski, F; Gonzalo, X | 1 |
| Chau, CH; Lee, J; Wong, CF; Wong, PC; Yew, WW | 1 |
| Hirose, T; Ikeda, T; Iwanaga, T; Kishikawa, R; Nishima, S; Tsurutani, H; Yokota, K | 1 |
| Abate, G; Miörner, H | 1 |
| Aman, K; Ebihara, M; Nakagawa, Y; Shimazu, K | 1 |
| González-Lahoz, JM; Laguna, F; Moreno, V; Valencia, ME | 1 |
3 review(s) available for amoxicillin and Tuberculosis, Drug-Resistant
| Article | Year |
|---|---|
SAR analysis of new anti-TB drugs currently in pre-clinical and clinical development.
Topics: Animals; Antitubercular Agents; Humans; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2014 |
Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment.
Topics: Amoxicillin; Antitubercular Agents; Azithromycin; Cilastatin; Clarithromycin; Clavulanic Acid; HIV Infections; Humans; Imipenem; Isoxazoles; Macrolides; Meropenem; Mycobacterium tuberculosis; Oxazolidinones; Randomized Controlled Trials as Topic; Thienamycins; Thioridazine; Treatment Outcome; Tuberculosis, Multidrug-Resistant; World Health Organization | 2015 |
Group 5 drugs for multidrug-resistant tuberculosis: individual patient data meta-analysis.
Topics: Adult; Amoxicillin; Antitubercular Agents; Clofazimine; Cohort Studies; Drug Therapy, Combination; Female; Humans; Isoxazoles; Linezolid; Logistic Models; Macrolides; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Oxazolidinones; Thioacetazone; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
8 other study(ies) available for amoxicillin and Tuberculosis, Drug-Resistant
| Article | Year |
|---|---|
In Reply: Synergy between amoxicillin and meropenem/clavulanate in drug-resistant tuberculosis.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acid; Humans; Meropenem; Tuberculosis, Multidrug-Resistant | 2018 |
In Vitro Activity of β-Lactams in Combination with β-Lactamase Inhibitors against Multidrug-Resistant Mycobacterium tuberculosis Isolates.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Clavulanic Acid; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Gene Expression; Humans; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Sulbactam; Thienamycins; Tuberculosis, Multidrug-Resistant | 2016 |
Is there a place for β-lactams in the treatment of multidrug-resistant/extensively drug-resistant tuberculosis? Synergy between meropenem and amoxicillin/clavulanate.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Clavulanic Acid; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Thienamycins; Tuberculosis, Multidrug-Resistant | 2013 |
Do beta-lactam-beta-lactamase inhibitor combinations have a place in the treatment of multidrug-resistant pulmonary tuberculosis?
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1995 |
[The combination of amoxicillin-clavulanic acid and ofloxacin in the treatment of multidrug-resistant Mycobacterium tuberculosis].
Topics: Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Clavulanic Acids; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Male; Ofloxacin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
Susceptibility of multidrug-resistant strains of Mycobacterium tuberculosis to amoxycillin in combination with clavulanic acid and ethambutol.
Topics: Amoxicillin; Antitubercular Agents; beta-Lactamases; Clavulanic Acid; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 1998 |
[A study of beta-lactamase activity of mycobacteria and clinical trial of penicillin/beta-lactamase inhibitor combinations in the treatment of drug-resistant Mycobacterium tuberculosis].
Topics: Amoxicillin; Ampicillin; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Drug Resistance, Multiple; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Mycobacterium avium Complex; Mycobacterium chelonae; Mycobacterium tuberculosis; Penicillins; Sulbactam; Tuberculosis, Multidrug-Resistant | 1999 |
[Multiresistant tuberculosis caused by Mycobacterium bovis and human immunodeficiency virus infection. Are there new therapeutic possibilities?].
Topics: Acetamides; Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Clavulanic Acid; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Isoniazid; Linezolid; Mycobacterium bovis; Oxazolidinones; Thioacetazone; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |